Researchers at the University of East Anglia have helped develop a new blood test to detect prostate cancer with greater accuracy than current methods.
New research shows that the Prostate Screening EpiSwitch (PSE) blood test is 94 per cent accurate — beating the currently used prostate-specific antigen (PSA) blood test.
The research team say that the new test shows significant potential as an accurate and rapid cancer screening diagnostic.
The test was developed by Oxford Biodynamics in collaboration with UEA, Imperial College London and Imperial College NHS Trust.
Prof Dmitry Pshezhetskiy, from UEA’s Norwich Medical School, said: “Prostate cancer is the most common cancer in men and kills one man every 45 minutes in the UK.
“There is currently no single te...
Read More
Recent Comments